Publications
349
Citations
6,038
Est. group size
~34
Recurring co-author estimate
Active years
29
Publishing since 1998
Typically publishes in teams of ~16 · 3% small-team papers (≤3 authors) · across 30 venues
- Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models
Blood · 2026
- Treatment for Relapsed Pediatric AML: Variability and Comparative Effectiveness of Current Approaches to Re-Induction
SSRN Electronic Journal · 2026
- Abstract 643: The Sean Karl Cohort: An international single-cell RNAseq study of paired patient Ewing sarcoma specimens.
Cancer Research · 2026
- A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Pediatric Blood & Cancer · 2025
- A phase 2 randomized study of chemoimmunotherapy with or without eflornithine (DFMO) in relapsed/refractory neuroblastoma: A Children’s Oncology Group (COG) report.
Journal of Clinical Oncology · 2025
- Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort
JNCI Journal of the National Cancer Institute · 2025
- 117 Impact of Secure Chat on Efficiency and Emergency Department Critical and Urgent Result Communication Rates
Annals of Emergency Medicine · 2025
- Abstract A016: ews-nf: A custom workflow for tumor cell annotation and analysis of single-cell RNA-sequencing of paired patient Ewing sarcoma specimens from the Sean Karl cohort
Cancer Research · 2025
- Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation
Blood · 2025
- Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity
Blood · 2025
- Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity
Blood · 2025
- Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1
Blood · 2025
- Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
JCO Precision Oncology · 2024
- Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines
Clinical Oncology · 2024
- Concurrent primary mediastinal germ cell tumor and acute myeloid leukemia: Case report of sustained remission and review of the literature
Pediatric Blood & Cancer · 2024
- Neuro-Oncology×35
- Pediatric Blood & Cancer×17
- Blood×14
- Journal of Clinical Oncology×13
- JCO Precision Oncology×9
- Andrea Franson
Medicine · University of Michigan
- Carl Koschmann
Medicine · University of Michigan
- Akash Deogharkar
Medicine · University of Michigan
- Chan Chung
Medicine · University of Michigan
- Dana Messinger
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile